The largest database of trusted experimental protocols

Hek293t lentix cells

Manufactured by Takara Bio
Sourced in United States

HEK293T LentiX cells are a well-characterized human embryonic kidney cell line that is commonly used for the production of lentiviral vectors. These cells are optimized for high-titer lentivirus production and are suitable for a variety of applications, including gene delivery, gene expression, and cell line development.

Automatically generated - may contain errors

20 protocols using hek293t lentix cells

1

Myoblast Culture from HML Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Myoblasts from the tibialis anterior of two HML patients (P1, P2) and a healthy control (C) were cultured in 4 volumes of Dulbecco’s modified essential medium (DMEM)(Gibco, Waltham, MA, USA) to 1 volume Medium 199 (Gibco) supplemented with 20% FBS (Gibco), 5 ng/ml recombinant human hepatocyte growth factor (Invitrogen, Waltham, MA, USA) and 50 μg/ml gentamycin. HEK 293T Lenti-X cells (Clontech, Mountain View, CA, USA) were cultured in DMEM (Gibco) supplemented with 1% Glutamax (Gibco), 10% FBS and 1% Pen Strep (Gibco). All cells were grown at 37°C with 5% CO2. All chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise stated. Studies including humans, where written informed consent was obtained from all participants, were approved by the Regional Ethics Committee for Medical Research at Umeå University (09–105M).
+ Open protocol
+ Expand
2

Lentiviral Production and Selection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lentivirus was produced by PEI (Polysciences Inc.) transfection of HEK293T LentiX cells (Clontech) with gene delivery vector co-transfected with packaging vectors pspax2 and pMD2.G as previously described23 . Supernatants were harvested 72h post-transfection and centrifuged at 20,000 rpm for 2h at 4°C. Virus containing pellets were resuspended in PBS and placed on cells dropwise. Selection of lentivirally-infected cells was achieved with either blasticydin or puromycin, both used at 2μg/ml.
+ Open protocol
+ Expand
3

Generating Luciferase-Expressing Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lentivirale particles were generated by co-transfection of HEK293T Lenti-X cells (Clontech) with packaging plasmids (pMD2.G, pMDLg/pRRE, pRSV-REV, Addgen) and the lentiviral transfervector (pLenti-III-UbC-Luc2, Applied Biological Materials Inc.) expressing Luciferase 2. After 48 and 72 hours the supernatants were pooled, filtered through a 45 um filter and ultracentrifuged at 87076 g 4°C for 2 h. The virus titers were determined by HIV p24 antigen test (Elecsys, Roche Diagnostics). MEB-Med-8A cells were transduced with virus particles (MOI 5) and thereafter selected with puromycin and validated for homogenous luciferase activity (Invitrogen).
+ Open protocol
+ Expand
4

Lentiviral Transduction and Selection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lentivirus was produced by PEI (Polysciences Inc.) transfection of HEK-293-T LentiX cells (Clontech) with gene delivery vector co-transfected with packaging vectors pspax2 and pMD2.G as previously described(Kadoch and Crabtree, 2013 (link)). Supernatants were harvested 72h post-transfection and centrifuged at 20,000 rpm for 2h at 4°C. Virus containing pellets were resuspended in PBS and placed on cells dropwise. Selection of lentivirally-infected cells was achieved with either blasticydin or puromycin, both used at 2μg/ml. Overexpression or knock-down (KD) efficiency was determined by Western blot analyses or RT-qPCR. shRNA constructs used are found in Table S3.
+ Open protocol
+ Expand
5

Lentiviral Transduction and Selection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lentivirus was produced by PEI (Polysciences) transfection of HEK293T LentiX cells (Clontech) with gene delivery vector co-transfected with packaging vectors pspax2 and pMD2.G as previously described (Kadoch and Crabtree, 2015 (link)). Viral supernatants were harvested 72 hr post-transfection and concentrated by ultracentrifugation at 20,000 rpm for 2.5 hr at 4°C. Virus containing pellets were resuspended in PBS and added dropwise to cells in the presence of 10 μg/mL polybrene. Selection of lentivirally-infected cells was achieved with puromycin used at 2 μg/ml. Knockdown efficiency and overexpression was measured by western blot analysis.
+ Open protocol
+ Expand
6

Overexpression of Braf Oncogene Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human BRAFP1 was cloned into pLenti-CMV-GFP-Puro (Addgene 25873) and pCDNA3, and mouse Braf-rs1 was cloned into pCCL.sin.PPT.hPGK.GFP.Wpre (L277, L. Naldini) or pCDNA3-neo. pMSCV-tTA (Addgene #18783) was used to induce Braf-rs1 expression in TRE-BPS MEFs. Lipofectamine 2000 was used for plasmid transfection. Lentivirus or retrovirus was produced in HEK293T LentiX cells (Clontech) co-transfected with VSVG, pMDL, and Rev or Eco helper plasmids, respectively. Viral supernatants were filtered and cells infected in the presence of 5μg/mL polybrene.
+ Open protocol
+ Expand
7

Lentiviral Luciferase Reporter Generation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lentivirale particle were generated by co-transfection of HEK293T Lenti-X cells (Clontech) with packaging plasmids (pMD2.G, pMDLg/pRRE, pRSV-REV, Addgene) and the lentiviral transfervector (pLenti-III-UbC-Luc2, Applied Biological Materials Inc.) expressing Luciferase 2. After 48 and 72 hours the supernatants were pooled, filtered through a 45 um filter and ultra centrifuged at 32000 rpm 4°C for 1h. The virus titers were determined by HIV p24 antigen test (Elecsys, Roche Diagnostics GmbH). MEB-Med-8A cells were transduced with virus particles (MOI 5) and thereafter selected with puromycin for cell clones that show stable luciferase expression (Invitrogen).
+ Open protocol
+ Expand
8

Lentiviral Production and Selection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lentivirus was produced by PEI (Polysciences Inc.) transfection of HEK293T LentiX cells (Clontech) with gene delivery vector co-transfected with packaging vectors pspax2 and pMD2.G as previously described23 . Supernatants were harvested 72h post-transfection and centrifuged at 20,000 rpm for 2h at 4°C. Virus containing pellets were resuspended in PBS and placed on cells dropwise. Selection of lentivirally-infected cells was achieved with either blasticydin or puromycin, both used at 2μg/ml.
+ Open protocol
+ Expand
9

Efficient Lentiviral Transduction for Stable Gene Delivery

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lentivirus production was obtained from PEI (Polysciences) transfection of HEK293T LentiX cells (Clontech) with co-transfection of the packaging vectors pspax2 and pMD2.G along with the gene delivery vector. Viral supernatants were collected 72 hours after transfection, underwent ultracentrifugation at 20,000 rpm for 2.5 hr at 4°C to concentrate, and then virus pellets were resuspended in PBS. For infection, the viral pellets were added to cells in a drop wise manner in the presence of polybrene (10 μg/mL). After 48 hours, the media containing the lentivirus was replaced and infected cells were selected by addition of puromycin (2 μg/mL) or blasticidin (10 µg/mL).
+ Open protocol
+ Expand
10

Lentiviral Transduction of Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lentivirus was produced in HEK293T LentiX cells (Clontech) by LT1 (Mirus Bio) transfection with gene delivery vector and packaging vectors GAG/POL and VSV plasmids.17 (link) Viral supernatants were collected 72 h after transfection and concentrated using the LentiX concentrator (Clontech). Virus containing pellets were resuspended in PBS and added dropwise on cells in presence of growth media supplemented with six ug/ml polybrene. Cells infected with lentivirus were selected using puromycin (Invivogen) at a concentration of one ug/ml for SKNMC, EW7, CHP100, HEK293T, HeLa and U2OS or two ug/ml for A673 and MRC5 in the growth medium. MSCs were selected with 0.75 ug/ml puromycin. Overexpression efficiency was determined by immunoblot analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!